Page last updated: 2024-08-24

1h-imidazo(4,5-b)pyridine and Hyperglycemia

1h-imidazo(4,5-b)pyridine has been researched along with Hyperglycemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Jiang, Y; Liang, G; Liu, Z; Qian, J; Wang, Y; Yang, L; Yang, X; Yin, S; Zhuang, F	1

Other Studies

1 other study(ies) available for 1h-imidazo(4,5-b)pyridine and Hyperglycemia

Article	Year
The imidazopyridine derivative X22 prevents diabetic kidney dysfunction through inactivating NF-κB signaling. Biochemical and biophysical research communications, 2020, 05-14, Volume: 525, Issue:4 Topics: Animals; Cell Line; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibrosis; Hyperglycemia; Hypoglycemic Agents; Imidazoles; Kidney; Kidney Function Tests; Kidney Tubules, Proximal; Mice, Inbred C57BL; Nephritis; NF-kappa B; Pyridines; Rats; Signal Transduction	2020

Article

Year

The imidazopyridine derivative X22 prevents diabetic kidney dysfunction through inactivating NF-κB signaling.

Biochemical and biophysical research communications, 2020, 05-14, Volume: 525, Issue:4

Topics: Animals; Cell Line; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibrosis; Hyperglycemia; Hypoglycemic Agents; Imidazoles; Kidney; Kidney Function Tests; Kidney Tubules, Proximal; Mice, Inbred C57BL; Nephritis; NF-kappa B; Pyridines; Rats; Signal Transduction

2020